We are encouraged by these new data, which reinforce our confidence that the Moderna Covid-19 vaccine should be protective against these newly detected variants," Stephane Bancel, Chief Executive Officer of Moderna, said in a statement.
The WHO had granted emergency use validation for the Pfizer-BioNTech Covid-19 vaccine on December 31, 2020, opening the door for countries to expedite their own regulatory approval processes to import and administer the vaccine.
The company is "fully cooperating" with the California Department of Public Health (CDPH) in investigating these reported adverse events, Moderna said on Tuesday.
We're grateful for all the scientists, researchers, manufacturing workers, and service members, who have worked tirelessly to make this breakthrough possible. It is truly a Christmas miracle, said the US president
The European Union is under massive pressure to approve potential vaccines after Britain and the United States began rolling out a drug produced by Pfizer and BioNtech.
The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5 million people worldwide and ravaged economies.
The bill, which says the government will cover all vaccine costs for Japan's 126 million residents, was approved by the upper house of parliament, having cleared the powerful lower house.
Moderna, whose results stem from a clinical trial of more than 30,000 participants, expects to have approximately 20 million doses ready to ship in the United States by year-end.